Effects of central administration of the nanomedicine on food intake and liver and brown fat metabolism (IMAGE)
Caption
Innovative core-crosslinked polymeric micelle -type nanomedicine loaded with CPT1A inhibitor C75-CoA, and the effects of central administration of the nanomedicine on food intake and liver and brown fat metabolism. Reprinted with permission from Garcia et al., Biomaterials Science 2023 (https://doi.org/10.1039/D2BM01751B).
Credit
Copyright Royal Chemical Society
Usage Restrictions
Reprinting is prohibited without permission.
License
Licensed content